Prevalence and Antibiotic Profile of Multidrug Resistance Gram-Negative Pathogens Isolated from Wound Infections at Two Tertiary Hospitals in Limpopo Province, South Africa: A Retrospective Study
Background: There is a high
mortality and morbidity associated with multidrug resistance pathogens. The
high rate of MDR isolates is gradually becoming a threat to the coverage of
antibiotics including the clinical outcome of infected patients. Methods: A 5-year laboratory based antibiotic susceptibility data from January 2016 to
December 2020 was reviewed to determine the most prevalent MDR pathogens
isolated from samples taken from patients with wound infections at Pietersburg
and Mankweng Hospitals. Results: A total of 792 pathogens were analyzed.
The most prevalent isolates were Klebsiellapneumoniae (23%), Pseudomonasaeruginosa (21.7%), Escherichiacoli (16%), Proteusmirabilis (13.5%), Acinetobacterbaumannii (9.1%) and Klebsiellaoxytoca (3.8%). The overall
prevalence of MDR isolates in this study was 38.1%. The distribution of MDR
prevalence amongst these isolates wasK.pneumoniae (20.8%), P.aeruginosa (18.8%), P.mirabilis (17.5%), E.coli (15.9%) and A.baumannii (8.3%). Of the 9
antibiotic agents tested, trimethoprim sulfamethoxazole, tigecycline and
cefepime had the highest levels of resistance. The highest level of resistance
was conferred by K.pneumoniae having 63% of isolates identified as MDR. The study could not determine
statistical significance of any determinant of MDR. Conclusion: The
study revealed that there is high rate of MDR pathogens (38.9%) in Limpopo.
Majority of the pathogens were K.pneumoniae from surgical ward, which also conferred high resistance levels. A proportion of
the MDR pathogens was identified as A. baumannii CRE pathogens and
is noteworthy in implementation aggressive infection prevention and control
strategies.
References
[1]
Alam, M.M., Islam, M.N., Hawlader, H., et al. (2021) Prevalence of Multidrug Resistance Bacterial Isolates from Infected Wound Patients in Dhaka, Bangladesh: A Cross-Sectional Study. International Journal of Surgery Open, 28, 56-62. https://doi.org/10.1016/j.ijso.2020.12.010
[2]
Magiorakos, A., Srinivasan, A., Carey, R.B., et al. (2011) Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance. Clinical Microbiology and Infection, 18, 268-281. https://doi.org/10.1111/j.1469-0691.2011.03570.x
[3]
Mulani, M.S., Kamble, E.E., Kumkar, S.N., et al. (2019) Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review. Frontiers in Microbiology, 10, Article No. 539. https://doi.org/10.3389/fmicb.2019.00539
[4]
Ram, S., Gupta, R., Gaheer, M. and Uppal, S. (2000) Prevalence of Multidrug Resistant Organisms. Indian Journal of Medical Research, 111, 118-120.
[5]
Sani, R.A., Garba, S.A., Oyewole, O.A. and Ibrahim, A. (2012) Antibiotic Resistance Profile of Gram Positive Bacteria Isolated from Wound Infections in Minna, Bida, Kontagora and Suleja Area of Niger State. Journal of Health Sciences, 2, 19-22. https://doi.org/10.5923/j.health.20120203.01
[6]
Ntirenganya, C., Manzi, O., Muvunyi, C.M. and Ogbuagu, O. (2022) High Prevalence of Antimicrobial Resistance among Common Bacterial Isolates in a Tertiary Healthcare Facility in Rwanda. American Journal of Tropical Medicine and Hygiene, 92, 865. https://doi.org/10.4269/ajtmh.14-0607
[7]
Feleke, T., Eshetie, S., Dagnew, M., et al. (2018) Multidrug-Resistant Bacterial Isolates from Patients Suspected of Nosocomial Infections at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. BMC Research Notes, 11, Article No. 602. https://doi.org/10.1186/s13104-018-3709-7 https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-018-3709-7
[8]
Kabanangi, F., Joachim, A., Nkuwi, E.J., et al. (2021) High Level of Multidrug-Resistant Gram-Negative Pathogens Causing Burn Wound Infections in Hospitalized Children in Dar es Salaam, Tanzania. International Journal of Microbiology, 2021, Article ID: 6644185. https://doi.org/10.1155/2021/6644185
[9]
Leski, T.A., Taitt, C.R., Bangura, U., et al. (2016) High Prevalence of Multidrug Resistant Enterobacteriaceae Isolated from Outpatient Urine Samples but Not the Hospital Environment in Bo, Sierra Leone. BMC Infectious Diseases, 16, Article No. 167. https://doi.org/10.1186/s12879-016-1495-1
[10]
Lord, J., Gikonyo, A., Miwa, A. and Odoi, A. (2021) Antimicrobial Resistance among Enterobacteriaceae, Staphylococcus aureus, and Pseudomonas spp. Isolates from Clinical Specimens from a Hospital in Nairobi, Kenya. PeerJ, 9, e11958. https://pubmed.ncbi.nlm.nih.gov/34557345 https://doi.org/10.7717/peerj.11958
[11]
Seyoum, A.G., Hailu, L.M. and Mulugeta, W.G. (2017) Prevalence of Multidrug Resistant Bacteria in Postoperative Wound Infections at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Archives of Medicine, 9, Article No. 12. https://www.archivesofmedicine.com
[12]
Adhikari, K., Basnyat, S. and Shrestha, B. (2020) Prevalence of Multidrug-Resistant and Extended-Spectrum Betalactamase Producing Bacterial Isolates from Infected Wounds of patients in Kathmandu Model Hospital. Nepal Journal of Science and Technology, 19, 171-179. https://doi.org/10.3126/njst.v19i1.29798 https://www.nepjol.info/index.php/NJST/article/view/29798
[13]
Chanda, W., Manyepa, M., Chikwanda, E., et al. (2019) Evaluation of Antibiotic Susceptibility Patterns of Pathogens Isolated from Routine Laboratory Specimens at Ndola Teaching Hospital: A Retrospective Study. PLOS ONE, 14, e0226676. https://doi.org/10.1371/journal.pone.0226676
[14]
Saha, S., Ghosh, P., Mitra, G., et al. (2018) Prevalence of Pathogenic Bacterial Isolates in Wound Infection and Their Antimicrobial Susceptibility Pattern: A Study Conducted at Burdwan Medical College and Hospital, India. International Journal of Recent Scientific Research, 9, 23891-23898. https://doi.org/10.24327/ijrsr.2018.0902.1557
[15]
Alali, W.Q., Alfouzan, W. and Dhar, R. (2021) Prevalence of Antimicrobial Resistance in Gram-Negative Clinical Isolates from a Major Secondary Hospital in Kuwait: A Retrospective Descriptive Study. Germs, 11, 498-511. https://doi.org/10.18683/germs.2021.1285
[16]
Jubeh, B., Breijyeh, Z. and Karaman, R. (2020) Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches. Molecules, 25, Article No. 2888. https://doi.org/10.3390/molecules25122888
[17]
Monnheimer, M., Cooper, P., Amegbletor, H.K., et al. (2021) High Prevalence of Carbapenemase-Producing Acinetobacter baumannii in Wound Infections, Ghana, 2017/2018. Microorganisms, 9, Article No. 537. https://pubmed.ncbi.nlm.nih.gov/33807838 https://doi.org/10.3390/microorganisms9030537
[18]
Hamid, O.M. (2022) The Emergence of Carbapenem Resistant Enterobacteriaceae Producing GIM-1 and SIM-1 Clinical Isolates in Khartoum-Sudan. Infection and Drug Resistance, 15, 2679-2684. https://doi.org/10.2147/IDR.S365983
[19]
Fehr, J., Hatz, C., Soka, I., et al. (2006) Risk Factors for Surgical Site Infection in a Tanzanian District Hospital: A Challenge for the Traditional National Nosocomial Infections Surveillance System Index. Infection Control & Hospital Epidemiology, 27, 1401-1404. https://doi.org/10.1086/509855
[20]
Ferreira, R.L., Da Silva, B.C.M., Rezende, G.S., et al. (2019) High Prevalence of Multidrug-Resistant Klebsiella Pneumoniae Harboring Several Virulence and β-Lactamase Encoding Genes in a Brazilian Intensive Care Unit. Frontiers in Microbiology, 10, Article No. 3198. https://doi.org/10.3389/fmicb.2018.03198
[21]
Ogalo, E.A., Owuor, C.O., Boor, K.G. and Mutai, K.K. (2017) High Prevalence of Multi-Drug Resistant Klebsiella pneumoniae in a Tertiary Teaching Hospital in Western Kenya. African Journal of Infectious Diseases, 10, 89-95. https://www.ajol.info/index.php/ajid/article/view/156778 https://doi.org/10.21010/ajid.v10i2.3
[22]
Al-Awkally, N.M., Ali, M.D., Al-Awkally, N.M. and Al-Awkally, R.M. (2019) Susceptibility Pattern of Klebsiella spp Isolated from Human Specimens in Darna, Shahat and Benghazi-Libya against Various Antibiotics.
[23]
Walters, M.S., Grass, J.E., Bulens, S.N., et al. (2019) Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015. Emerging Infectious Diseases, 25, 1281-1288. https://pubmed.ncbi.nlm.nih.gov/31211681 https://doi.org/10.3201/eid2507.181200
[24]
Yahav, D., Giske, C.G., Gramatniece, A., Abodakpi, H., Tam, V.H. and Leibovici, L. (2020) New β-Lactam-β-Lactamase Inhibitor Combinations. Clinical Microbiology Reviews, 34, e00115-20. https://pubmed.ncbi.nlm.nih.gov/33177185 https://doi.org/10.1128/CMR.00115-20